Paper24366362
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.
Rumi E and 20 others. Blood, 2014. Cited by 483 papers, by iCite.
Cite this record
ConductScience Library. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Papers, record 24366362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24366362
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calreticulin | Major topic |
| Janus Kinase 2 | Major topic |
| Mutation | Major topic |
| Thrombocythemia, Essential | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Alleles | |
| Cell Transformation, Neoplastic | |
| Codon | |
| Exons | |
| Female | |
| Granulocytes | |
| Humans | |
| Male | |
| Middle Aged | |
| Myeloproliferative Disorders | |
| Polycythemia Vera | |
| Primary Myelofibrosis | |
| Prognosis | |
| Receptors, Thrombopoietin | |
| Thrombosis | |
| Young Adult |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P 23257 | Austrian Science Fund FWF | Austria | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 24627549 | Two faces of ET: CALR and JAK2. | https://conductscience.org/library/papers/24627549 |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17389763 | The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera. | Blood | 2007 | https://conductscience.org/library/papers/17389763 | PubMed |
| 2 | 22898600 | JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone. | Blood | 2012 | https://conductscience.org/library/papers/22898600 | PubMed |
| 3 | 21074499 | Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling. | Cancer Cell | 2010 | https://conductscience.org/library/papers/21074499 | PubMed |
| 4 | 16325696 | Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. | Lancet | 2005 | https://conductscience.org/library/papers/16325696 | PubMed |
| 5 | 12239137 | The World Health Organization (WHO) classification of the myeloid neoplasms. | Blood | 2002 | https://conductscience.org/library/papers/12239137 | PubMed |
| 6 | 23033268 | Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). | Blood | 2012 | https://conductscience.org/library/papers/23033268 | PubMed |
| 7 | 21228032 | Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms. | Haematologica | 2011 | https://conductscience.org/library/papers/21228032 | PubMed |
| 8 | 23216616 | Cardiovascular events and intensity of treatment in polycythemia vera. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23216616 | PubMed |
| 9 | 19692701 | Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. | Blood | 2009 | https://conductscience.org/library/papers/19692701 | PubMed |
| 10 | 16461300 | Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status. | Haematologica | 2006 | https://conductscience.org/library/papers/16461300 | PubMed |
| 11 | 20631743 | A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. | Leukemia | 2010 | https://conductscience.org/library/papers/20631743 | PubMed |
| 12 | 21205761 | Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21205761 | PubMed |
| 13 | 15858187 | A gain-of-function mutation of JAK2 in myeloproliferative disorders. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15858187 | PubMed |
| 14 | 22802311 | Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22802311 | PubMed |
| 15 | 22160036 | Genetic and epigenetic complexity in myeloproliferative neoplasms. | Hematology Am Soc Hematol Educ Program | 2011 | https://conductscience.org/library/papers/22160036 | PubMed |
| 16 | 15793561 | A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. | Nature | 2005 | https://conductscience.org/library/papers/15793561 | PubMed |
| 17 | 22373697 | Calreticulin signaling in health and disease. | Int J Biochem Cell Biol | 2012 | https://conductscience.org/library/papers/22373697 | PubMed |
| 18 | 18160670 | Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice. | Blood | 2008 | https://conductscience.org/library/papers/18160670 | PubMed |
| 19 | 16029446 | Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. | Br J Haematol | 2005 | https://conductscience.org/library/papers/16029446 | PubMed |
| 20 | 8516591 | Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? | Stat Med | 1993 | https://conductscience.org/library/papers/8516591 | PubMed |
Cited by260
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 483 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42758401 | Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026. | Curr Hematol Malig Rep | 2026 | https://conductscience.org/library/papers/42758401 | PubMed |
| 42738297 | The Current Landscape of Pulmonary Hypertension in Myeloproliferative Neoplasms. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738297 | PubMed |
| 42613432 | Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms. | Leukemia | 2026 | https://conductscience.org/library/papers/42613432 | PubMed |
| 42602648 | Adolescent and Young Adult versus Older Adult Philadelphia-Negative Myeloproliferative Neoplasms: A Single-Center Experience from the MENA Region. | J Blood Med | 2026 | https://conductscience.org/library/papers/42602648 | PubMed |
| 42271111 | NGS and emerging molecular scenarios in chronic myeloproliferative neoplasms: a case of double mutated polycythemia vera. | Ann Hematol | 2026 | https://conductscience.org/library/papers/42271111 | PubMed |
| 42245690 | Management of splenomegaly in patients with myelofibrosis in the era of JAK inhibitors: a comprehensive review. | Front Oncol | 2026 | https://conductscience.org/library/papers/42245690 | PubMed |
| 42154105 | Association between JAK2 mutations and thoracic aortic aneurysms in myeloproliferative neoplasms. | J Thromb Thrombolysis | 2026 | https://conductscience.org/library/papers/42154105 | PubMed |
| 42116396 | Recurrent central retinal artery occlusion as the initial manifestation of essential thrombocythemia: A case report. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/42116396 | PubMed |
| 42043737 | Thrombopoietin Receptor MPL in Hematopoiesis and Myeloproliferative Neoplasms: Physiological Roles and Pathogenic Mechanisms. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/42043737 | PubMed |
| 41939250 | Response to therapy and prognosis according to molecular characterization in CALR-mutated essential thrombocythemia. | Hemasphere | 2026 | https://conductscience.org/library/papers/41939250 | PubMed |
| 41857563 | Obesity supersizes macrophage and neutrophil activation after stroke while lipid droplets play a protective role. | J Neuroinflammation | 2026 | https://conductscience.org/library/papers/41857563 | PubMed |
| 41776088 | From essential thrombocythemia to polycythemia vera (ET-2-PV): rationale and design of a multicenter ELN study. | Ann Hematol | 2026 | https://conductscience.org/library/papers/41776088 | PubMed |
| 41721193 | Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis. | Int J Hematol | 2026 | https://conductscience.org/library/papers/41721193 | PubMed |
| 41589191 | Budd-Chiari Syndrome Secondary to Essential Thrombocythaemia Complicated by Acquired Von Willebrand Disease and Mimicking Hepatic Malignancy: A Case Report. | Cureus | 2025 | https://conductscience.org/library/papers/41589191 | PubMed |
| 41436639 | Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms. | Leukemia | 2026 | https://conductscience.org/library/papers/41436639 | PubMed |
| 41051280 | Drug Repositioning of Pegbing® for Essential Thrombocythemia: Insights from PK/PD Modeling and Extrapolation. | Clin Pharmacol Ther | 2026 | https://conductscience.org/library/papers/41051280 | PubMed |
| 40772034 | Case Report: Myelodysplastic/myeloproliferative neoplasm with concurrent SF3B1, ASXL1, JAK2 and CBL mutations and <15% bone marrow ringed sideroblasts. | Front Oncol | 2025 | https://conductscience.org/library/papers/40772034 | PubMed |
| 40668166 | Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review. | JACC CardioOncol | 2025 | https://conductscience.org/library/papers/40668166 | PubMed |
| 40625825 | Bleeding Complications in JAK2-Variant Essential Thrombocythemia: A Revisit in 2025. | EJHaem | 2025 | https://conductscience.org/library/papers/40625825 | PubMed |
| 40568201 | Hemoglobin-associated CALR in proximal tubule cells can be used as a biomarker for idiopathic membranous nephropathy. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40568201 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CALR | 811 | PubTator's text mining | https://conductscience.org/library/genes/811 | NCBI Gene |
| EPO | 2056 | PubTator's text mining | https://conductscience.org/library/genes/2056 | NCBI Gene |
| JAK2 | 3717 | PubTator's text mining | https://conductscience.org/library/genes/3717 | NCBI Gene |
| MPL | 4352 | PubTator's text mining | https://conductscience.org/library/genes/4352 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24366362
GET https://conductscience.org/api/papers/v1/24366362/authors?page=2